Role of epiregulin levels in polycystic ovary syndrome patients: new findings and clinical significance
Reduced epiregulin levels may contribute to the pathophysiology of polycystic ovary syndrome, highlighting its potential as a biomarker and therapeutic target. Further studies are needed to explore the underlying mechanisms and clinical implications.
Authors
- Güzin Fidan Yaylalı (ORCID: https://orcid.org/0000-0003-0012-4700)
- Sadettin Çalışkan (ORCID: https://orcid.org/0000-0002-9218-581X)
- Şenay Topsakal (ORCID: https://orcid.org/0000-0003-4575-5653)
- Fatih Altıntaş
- Semin Melahat Fenkçi (ORCID: https://orcid.org/0000-0002-5658-459X)
Institutions
- Üsküdar University (TR)
- Pamukkale University (TR)
Publication Details
- Journal
- Revista da Associação Médica Brasileira
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1590/1806-9282.20242048
- Citations
- 1
- Primary Topic
- Ovarian function and disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.70